Shares continue to display relative strength as buying pressure accumulates. It’s the kind of stock we want to include in our portfolio — one that is trending well and receiving positive earnings estimate revisions.

Read more →

Further upside is likely based on promising sales and earnings growth metrics. We expect it to outperform the market over the next 3-6 months (just as it has over the past several months).

Read more →